期刊文献+

生物制剂治疗幼年型特发性关节炎新进展 被引量:3

生物制剂治疗幼年型特发性关节炎新进展
原文传递
导出
摘要 幼年特发性关节炎(juvenile idiopathic arthritis, JIA)是儿童期一种常见的慢性结缔组织病,表现为16周岁以前发病,持续时间超过6周,原因不明的关节疼痛、僵硬、肿胀等关节炎病变。以前曾用“幼年类风湿关节炎(juvenile rheumatoid arthritis)”和“幼年慢性关节炎(juvenile ehronie arthritis)”诊断本病。Ravelli等研究证实,25%-70%的JIA患者发病后10年中仍处于疾病活动状态。
出处 《中国实用儿科杂志》 CSCD 北大核心 2012年第8期627-632,共6页 Chinese Journal of Practical Pediatrics
基金 广州市医药卫生科技项目(20121A011055) 广东省自然科学基金(9151026003000004)
关键词 幼年特发性关节炎 生物制剂 juvenile idiopathic arthritis (JIA) biologics
  • 相关文献

参考文献50

  • 1Ravelli A, Martini A.Juvenile idiopathic arthritis [J].Lancet, 2007,369(9563) : 767-778.
  • 2Magni-Manzoni S, Pistorio A, Labo E, et al.A longitudinal analy- sis of physical functional disability over the course of juvenile id- iopathic arthritis [ J ].Ann Rheum Dis, 2008,67 (8): 1159-1164.
  • 3Hyrich KL, Lal SD, Foster HE, et al.Disease activity and disabil- ity in children with juvenile idiopathic arthritis one year follow- ing presentation to pediatric rheumatology: results from the Childhood Arthritis Prospective Study [J].Rheumatology (Ox- ford), 2010,49( 1 ) : 116-122.
  • 4Danner S, Sordet C, Terzic J, et aLEpidemiology of juvenile idio- pathic arthritis in Alsace, France[J].J Rheumatol, 2006, 33 : 1377-13gl.
  • 5Petty RE, Southwood TR, Manners P, et al.International leagu- of associations for rheumatology, international league of associa- tions for rheumatology classification of juvenile idiopathic arthri- tis: second revision, Edmonton, (2001 ) [ J ] .J Rheumatol, 2004, 31 : 390-392.
  • 6Vilca I, Munitis PG, Pistorio A, et al.Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic ar- thritis: analysis of the PRINTO methotrexate trial [J].Ann Rheum Dis,2010,69(8) : 1479-1483.
  • 7Silverman E, Mouy R, Spiegel L, et al.Leflunomide or methotrex- ate for juvenile rheumatoid arthritis [J ] .N Engl J Med, 2005,352 (16) : 1655-1666.
  • 8Lovell DJ, Giannini EH, Reiff A, et al.Etanercept in children with polyarticular juvenile rheumatoid arthritis [J].N Engl J Med, 2000,342 : 763-769.
  • 9Lovell DJ, Reiff A, Jones OY, et al.Long-term safety and effica- cy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis[J].Arthritis Rheum, 2006,54 : 1987-1994.
  • 10Lovell DJ, Reiff A, Ilowite NT, et al.Safety and efficacy of up to eight years of continuous etanercept therapy in patients with ju- venile rheumatoid arthritis [J].Arthritis Rheum, 2008,58 (5) : 1496-1504.

同被引文献42

  • 1刘闰平,葛俊德,钟颖,郑淇,孙蓉.基于干预细胞因子风暴文献挖掘的中医药治疗重症新型冠状病毒肺炎探讨[J].中草药,2020,51(5):1096-1105. 被引量:61
  • 2Cimaz R, yon Scheven A, Hofer M. Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease[J]. Swiss Med Wkly, 2012, 142: w13582.
  • 3Vannucci G, Cantarini L, Giani T, et al. Glueocorticoids in the management of systemic juvenile idiopathic arthritis[J]. Pediatric Drugs, 2013, 15: 343-349.
  • 4Wittkowski H, Frosch M, Wulffraat N, et al. S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin [J]. Arthritis Rheum, 2008, 58: 3924-3931.
  • 5Froseh M, Ahlmann M, Vogl T, et al. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-lbeta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis[J]. Arthritis Rheum, 2009, 60: 883-891.
  • 6Zhang Y, Macaubas C, Gupta S, et al. A160: role of inter- leukin-1 in abnormal monoeyte phenotype in systemic onset juve- nile idiopathic arthritis[J]. Arthritis Rheumatol, 2014, 66 Suppl 11 : S207-S208.
  • 7Maeno N, Takei S, Imanaka H, et al. Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-aetivation syn- drome[J]. Arthritis Rheum, 2004, 50: 1935-1938.
  • 8Fujii T, Nojima T, Yasuoka H, et al. Cytokine and immuno- genetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease[J]. Rheumatology (Ox- ford), 2001, 40: 1398-1404.
  • 9Benz R, Siciliano RD, Stussi G, et al. Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemia[J]. Eur J Haematol, 2009, 82: 194-200.
  • 10Yokota S, Kikuchi M, Nozawa T, et al. Pathogenesis of systemicinflammatory diseases in childhood: "Lessons from clinical trials of anti-eytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associ- ated periodic fever syndrome" [J]. Mod Rheumatol, 2014, 5: 1- 10.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部